Clinical Trial Update: Safety and Efficacy of Extracorporeal Photoimmune Therapy With UVADEX for the Treatment of Crohn's Disease [Phase 2]

View source ↗

Summary

Phase 2 trial update reporting safety and efficacy of Extracorporeal Photoimmune Therapy with UVADEX for Crohn's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• UVADEX (methoxsalen)

Snippet

Sponsor: Mallinckrodt | Conditions: Crohn's Disease | Phase 2 | Status: COMPLETED